DK2978414T3 - Sammensætning omfattende hydrocortison - Google Patents

Sammensætning omfattende hydrocortison Download PDF

Info

Publication number
DK2978414T3
DK2978414T3 DK14727028.4T DK14727028T DK2978414T3 DK 2978414 T3 DK2978414 T3 DK 2978414T3 DK 14727028 T DK14727028 T DK 14727028T DK 2978414 T3 DK2978414 T3 DK 2978414T3
Authority
DK
Denmark
Prior art keywords
hydrocortison
composition including
composition
including hydrocortison
Prior art date
Application number
DK14727028.4T
Other languages
English (en)
Inventor
Hiep Huatan
Richard Ross
Martin Whitaker
Norbert Poellinger
Annette Grave
Original Assignee
Diurnal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diurnal Ltd filed Critical Diurnal Ltd
Application granted granted Critical
Publication of DK2978414T3 publication Critical patent/DK2978414T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
DK14727028.4T 2013-05-17 2014-05-12 Sammensætning omfattende hydrocortison DK2978414T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1308933.9A GB201308933D0 (en) 2013-05-17 2013-05-17 Paediatric composition
PCT/GB2014/051442 WO2014184525A1 (en) 2013-05-17 2014-05-12 Composition comprising hydrocortisone

Publications (1)

Publication Number Publication Date
DK2978414T3 true DK2978414T3 (da) 2020-08-24

Family

ID=48746932

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14727028.4T DK2978414T3 (da) 2013-05-17 2014-05-12 Sammensætning omfattende hydrocortison

Country Status (25)

Country Link
US (1) US9649280B2 (da)
EP (1) EP2978414B1 (da)
JP (1) JP6371379B2 (da)
KR (1) KR102219919B1 (da)
CN (1) CN105120848B (da)
AU (1) AU2014267041B2 (da)
BR (1) BR112015028025B1 (da)
CA (1) CA2909060C (da)
CY (1) CY1123284T1 (da)
DK (1) DK2978414T3 (da)
ES (1) ES2813382T3 (da)
GB (2) GB201308933D0 (da)
HK (1) HK1214131A1 (da)
HR (1) HRP20201315T1 (da)
HU (1) HUE050917T2 (da)
IL (1) IL242275B (da)
LT (1) LT2978414T (da)
MX (1) MX2015015759A (da)
PL (1) PL2978414T3 (da)
PT (1) PT2978414T (da)
RS (1) RS60734B1 (da)
RU (1) RU2664678C2 (da)
SI (1) SI2978414T1 (da)
WO (1) WO2014184525A1 (da)
ZA (1) ZA201507210B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201119985D0 (en) 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201308933D0 (en) 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition
US20190180872A1 (en) * 2017-12-12 2019-06-13 International Business Machines Corporation Second Opinion Decision Support Using Patient Electronic Medical Records

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69101291T2 (de) 1990-08-30 1994-07-07 Senju Pharma Co Zusammensetzung zur kontrollierten Abgabe von Medikamenten.
CA2244421A1 (en) 1996-01-16 1997-07-24 Advanced Polymer Systems, Inc. Topical delivery of drugs to the lower gastrointestinal tract
KR20040016202A (ko) * 2002-08-16 2004-02-21 주식회사 제이알팜 쓴맛이 차폐된 히드로코르티손 경구용 약제 조성물 및 그제조방법
SE0401031D0 (sv) 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
JP2007533697A (ja) 2004-04-22 2007-11-22 デュオコート エービー グルココルチコイド救急治療用の医薬組成物
ZA200701576B (en) * 2004-04-30 2008-09-25 Astellas Pharma Inc Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition
MXPA06013850A (es) * 2004-05-31 2007-03-02 Almirall Lab Combinaciones que comprenden agentes antimuscarinicos y corticosteroides.
US20070281007A1 (en) * 2004-08-27 2007-12-06 Jacob Jules S Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
RU2290940C2 (ru) * 2004-10-18 2007-01-10 Государственное образовательное учреждение высшего профессионального образования "Нижегородская Государственная Медицинская академия" МЗ РФ (ГОУ ВПО НижГМА) Средство для коррекции острой почечной недостаточности при токсическом гепаторенальном синдроме, индуцированном четыреххлористым углеродом, и способ коррекции острой почечной недостаточности при токсическом гепаторенальном синдроме, индуцированном четыреххлористым углеродом
BRPI0611075A2 (pt) * 2005-06-03 2010-08-03 Elan Pharma Int Ltd formulações de acetaminofeno em nanopartìcula
EP2120868A4 (en) * 2007-04-11 2010-08-25 Perrigo Israel Phamaceuticals LOW-DOSED MOMETASON FORMULATIONS
GB0817120D0 (en) 2008-09-19 2008-10-29 Diurnal Ltd Treatment of adrenal insufficiency
US20120183610A1 (en) 2009-04-07 2012-07-19 Lennernaes Hans glucocorticoid therapy
LT3403654T (lt) * 2009-10-01 2019-09-10 Adare Development I, L.P. Geriamosios kortikosteroido kompozicijos
SG10201407965XA (en) * 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
PE20131024A1 (es) 2010-05-20 2013-10-10 Duocort Pharma Ab Composiciones basadas en glucocorticoides
GB201119985D0 (en) 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201308933D0 (en) 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition

Also Published As

Publication number Publication date
US9649280B2 (en) 2017-05-16
AU2014267041A1 (en) 2015-10-15
BR112015028025A8 (pt) 2019-12-31
GB201308933D0 (en) 2013-07-03
HUE050917T2 (hu) 2021-01-28
KR20160011205A (ko) 2016-01-29
ZA201507210B (en) 2017-07-26
LT2978414T (lt) 2020-09-25
GB2527233A (en) 2015-12-16
RS60734B1 (sr) 2020-09-30
CY1123284T1 (el) 2021-12-31
US20160081942A1 (en) 2016-03-24
MX2015015759A (es) 2016-03-15
CN105120848A (zh) 2015-12-02
PL2978414T3 (pl) 2020-11-16
PT2978414T (pt) 2020-08-27
RU2015150303A3 (da) 2018-03-26
BR112015028025A2 (pt) 2017-07-25
EP2978414B1 (en) 2020-07-22
SI2978414T1 (sl) 2020-10-30
HK1214131A1 (zh) 2016-07-22
CN105120848B (zh) 2019-06-04
AU2014267041B2 (en) 2018-11-22
KR102219919B1 (ko) 2021-02-25
CA2909060A1 (en) 2014-11-20
WO2014184525A1 (en) 2014-11-20
HRP20201315T1 (hr) 2020-11-27
GB2527233B (en) 2017-07-05
NZ712756A (en) 2020-12-18
CA2909060C (en) 2020-03-10
BR112015028025B1 (pt) 2022-11-29
EP2978414A1 (en) 2016-02-03
IL242275B (en) 2018-08-30
ES2813382T3 (es) 2021-03-23
JP6371379B2 (ja) 2018-08-08
RU2015150303A (ru) 2017-06-22
RU2664678C2 (ru) 2018-08-21
GB201516973D0 (en) 2015-11-11
JP2016518439A (ja) 2016-06-23

Similar Documents

Publication Publication Date Title
DK3042540T3 (da) Elektrotermske sammensætninger
DK3077047T3 (da) Aramcholsalte
DK3027750T3 (da) Biokatalytisk sammensætning
DK3060460T3 (da) Saddel
DK3027598T3 (da) Oxoquinazolinyl-butanamidderivater
UY4325S (es) Otomana
DK2956698T3 (da) Bindestrimler
DK3052081T3 (da) Pastil
DK2946640T3 (da) Langmuir-probe
DK3071227T3 (da) Fiskevaccine
FR3015291B1 (fr) Composition antiprurigineuse
DE102013106534B8 (de) Chromatographiepipettenspitze
ES2967618T3 (es) Composición pediculicida
DK2978414T3 (da) Sammensætning omfattende hydrocortison
DE112014001252A5 (de) Aufbissschiene
DK2981168T3 (da) Laminitiskile
FR3008288B1 (fr) 2sap
DK3082855T3 (da) Sammensætning
DE112014005422A5 (de) Friktionsfalschdrallaggregat
BR112016000501A2 (pt) Nalador
UA26169S (uk) Рукавиця
UA26161S (uk) Рукавиця
UA26152S (uk) Рукавиця
UA27974S (uk) Втулка
UA27964S (uk) Втулка